Real-World Effectiveness of Up to 12-Month Tralokinumab Treatment in Adults With Atopic Dermatitis Who Previously Discontinued Dupilumab or Janus Kinase Inhibitors. J of Skin 2026, 10 (2), s728. https://doi.org/10.25251/wx06pe13.